We found significant correlation of EGFR expression and tumor stage (P = 0.042), β-catenin and tumor size (P = 0.025) and stage (P = 0.031), and of EGFR expression and β-catenin cytoplasmic/nuclear expression and cyclin-D1 immunoactivity (P < 0.0001 for both) (Table 2). Here, CCND1 is linked to neoplasm.